Here are five key notes:
1. In his new role, Mr. Ennis will be responsible for optimizing the organizational structure to accelerate Implanet’s JAZZ technology adoption and growth in the market.
2. Mr. Ennis has 30 years of experience developing and growing medical technology companies. He had a long tenure at Stryker in marketing and management roles in the United States and Europe.
3. Mr. Ennis served as Empi president and president of international for Wright Medical Group. He has been on the Implanet board as the independent board director and special advisor for the past two years.
4. Implanet’s American subsidiary has a sales team and more than 25 agencies covering 60 percent of the country.
5. The Implanet technology applies sublaminar band technology to the deformity and degenerative spine market segments.
“We are delighted to be able to welcome Brian to lead Implanet’s US management team,” said Implanet CEO Ludovic Lastennet. “His experience, strategic vision and managerial skills will enable him to successfully execute Implanet’s ambitious growth plan in the United States.”
More articles on spine devices:
Smith & Nephew, Zimmer Biomet, Medovex & more: 20 key notes
Global non-fusion spinal device market to grow: 3 points
Medtech sells 2 ROSA Brain robots in US: 3 quick notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
